Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Mitoxantrone Hydrochloride for Injection

Approval Number

国药准字H32020964

Company江苏恒瑞医药股份有限公司

Registration Date

August 31, 2020

Drug Information

Generic Name

注射用盐酸米托蒽醌

Trade Name

恒恩

Brand Name

恒恩

Dosage Form

注射剂

Strength

5mg(按C22H28N406计)

Drug Type

化学药品

Registration Date

August 31, 2020

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区临港产业区东晋路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用盐酸米托蒽醌 - NMPA 批准文号 | MedPath